
Most common adverse reactions (≥ 20%) were edema, fatigue, nausea, diarrhea, musculoskeletal pain, and dyspnea. The most common Grade 3 to 4 laboratory abnormalities (≥ 2%) were decreased lymphocytes, decreased albumin, decreased sodium, increased gamma-glutamyltransferase, increased amylase, increased ALT, increased lipase, increased AST, and decreased hemoglobin.
from FDA,2023.03
Tepotinib: Common and Serious Adverse ReactionsThis drug can cause various adverse reactions. Very common (incidence >10%) include: fluid retention leading to edema (especially ···【more】
Article source:Lucius LaosRelease date:2026-06-18Recommended:96
Managing Side Effects During Tepotinib TreatmentDuring the use of tepotinib, if severe side effects occur, patients should not self-manage but rely on professional guidance from he···【more】
Article source:Lucius LaosRelease date:2026-06-16Recommended:100
Tepotinib-Associated Risk of Liver Function Abnormalities and Liver FailureTepotinib may cause abnormalities in liver function blood test results, and one patient in clinical trial···【more】
Article source:Lucius LaosRelease date:2026-06-15Recommended:113
Side Effects of TepotinibPatients should schedule regular follow-ups during treatment with Tepotinib and closely monitor any changes in their physical condition. If symptoms such a···【more】
Article source:Lucius LaosRelease date:2026-03-24Recommended:146

Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com

Name: Lucius

Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643